AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On May 8, 2025,
(HUM) saw a significant increase in trading volume, with a total of $313 million in shares exchanged, marking a 58.46% rise from the previous day. This surge placed at the 332nd position in terms of trading volume for the day. The stock price of Humana rose by 0.09%, marking the second consecutive day of gains, with a total increase of 0.63% over the past two days.Humana Inc. reported its first-quarter 2025 financial results, with earnings per share (EPS) of $10.30 on a GAAP basis and an adjusted EPS of $11.58. The company's insurance segment benefit ratio for the first quarter was 87.4%, aligning with its previously disclosed expectation of approximately 87.5%. Humana also affirmed its adjusted full-year 2025 EPS guidance of approximately $16.25.
On April 17, 2025, Humana's Board of Directors declared a quarterly cash dividend of $0.885 per share, payable on July 25, 2025, to stockholders of record as of June 27, 2025. This dividend announcement is part of Humana's ongoing commitment to returning value to its shareholders.
Humana Inc. announced the dates for its first-quarter 2025 earnings release and an investor conference. The company will release its financial results for the first quarter of 2025 on April 30, 2025, and host a live question-and-answer session on the same day. Additionally, Humana will host an Investor Conference on June 16, 2025, providing further insights into its financial performance and strategic initiatives.
Bronstein, Gewirtz & Grossman, LLC and Levi & Korsinsky are investigating potential claims on behalf of purchasers of Humana Inc. shares, focusing on potential securities fraud allegations. These investigations are part of ongoing efforts to ensure transparency and accountability in the financial markets.

Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Dec.24 2025

Dec.24 2025

Dec.23 2025

Dec.23 2025

Dec.23 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet